glp-1 receptor agonist function agonists for individualized treatment of type 2 diabetes mellitus Evolution of GLP‐1 Receptor Agonists
Description
A summary of all clinical trials mentioned can be found in Table 2
[DOI] [PMC free article] [PubMed] [Google Scholar] 48.Sridharan K., Sivaramakrishnan G
Pi-Sunyer et al
However, no cause-effect association between the use of GLP-1 receptor agonists and more serious infections has been observed
Liraglutides generic versions provide a lower-cost alternative with effective treatment for diabetes and weight loss
Standard dosing follows a step-up schedule, increasing from 0.25 mg to 2.4 mg, as used in most trials
